Sendai virus-based reprogramming of mesenchymal stromal/stem cells from umbilical cord wharton’s jelly into induced pluripotent stem cells

Methods in Molecular Biology

Volumn 1357, Issue , 2016, Pages 33-44

  Miere, Cristian ^a   Devito, Liani ^a   Ilic, Dusko ^a  

^a NONE

Author keywords

Adaption to feeder free culture conditions; IPSC; MSC; Reprogramming; Sendai virus; Umbilical cord; Vitrification

Indexed keywords

VIRUS VECTOR; CULTURE MEDIUM;

CRYOPRESERVATION; FEEDER CELL; FIBROBLAST; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; SENDAI VIRUS; STEM CELL CULTURE; THAWING; VIRUS DETECTION; WHARTON JELLY; CELL CULTURE; CELL CULTURE TECHNIQUE; CELL DIFFERENTIATION; CELL REPROGRAMMING TECHNIQUE; CELL SEPARATION; CULTURE MEDIUM; CYTOLOGY; GENE VECTOR; GENETICS; HUMAN; INDUCED PLURIPOTENT STEM CELL; PROCEDURES; UMBILICAL CORD; VITRIFICATION;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL SEPARATION; CELLS, CULTURED; CELLULAR REPROGRAMMING; CELLULAR REPROGRAMMING TECHNIQUES; CRYOPRESERVATION; CULTURE MEDIA; FIBROBLASTS; GENETIC VECTORS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MESENCHYMAL STROMAL CELLS; SENDAI VIRUS; UMBILICAL CORD; VITRIFICATION; WHARTON JELLY;

EID: 84952685263     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/7651_2014_163     Document Type: Chapter

References (24)

1. Loh YH, Yang L, Yang JC et al (2011) Genomic approaches to deconstruct pluripotency. Annu Rev Genomics Hum Genet 12:165-185
2. Inoue H, Yamanaka S (2011) The use of induced pluripotent stem cells in drug development. Clin Pharmacol Ther 89:655-661
3. Egawa N, Kitaoka S, Tsukita K et al (2012) Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci Transl Med 4:145ra104
4. Hou Z, Zhang J, Schwartz MP et al (2013) A human pluripotent stem cell platform for assessing developmental neural toxicity screening. Stem Cell Res Ther 4(Suppl 1):S12
5. Paşca SP, Portmann T, Voineagu I et al (2011) Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nat Med 17:1657-1662
6. Miller JD, Ganat YM, Kishinevsky S et al (2013) Human iPSC-based modeling of lateonset disease via progerin-induced aging. Cell Stem Cell 13:691-705
7. Takahashi K, Tanabe K, OhnukiMet al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872
8. Narsinh KH, Plews J, Wu JC (2011) Comparison of human induced pluripotent and embryonic stem cells: fraternal or identical twins? Mol Ther 19:635-638
9. Malik N, Rao M (2013) A review of the methods for human iPSC derivation. Methods Mol Biol 997:23-33
10. Fusaki N, Ban H, Nishiyama A (2009) Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 85:348-362
11. Nishishita N, Shikamura M, Takenaka C et al (2012) Generation of virus-free induced pluripotent stem cell clones on a synthetic matrix via a single cell subcloning in the naïve state. PLoS One 7(6):e38389
12. Ono M, Hamada Y, Horiuchi Y et al (2012) Generation of induced pluripotent stem cells from human nasal epithelial cells using a Sendai virus vector. PLoS One 7:e42855
13. Kudva YC, Ohmine S, Greder LV et al (2012) Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes. Stem Cells Transl Med 1:451-461
14. Jin ZB, Okamoto S, Xiang P et al (2012) Integration-free induced pluripotent stem cells derived from retinitis pigmentosa patient for disease modeling
15. Merling RK, Sweeney CL, Choi U et al (2013) Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34 + cells. Blood 121:e98-e107
16. Wakao H, Yoshikiyo K, Koshimizu U et al (2013) Expansion of functional human mucosal-associated invariant T cells via reprogramming to pluripotency and redifferentiation. Cell Stem Cell 12:546-558
17. Kim DW, Staples M, Shinozuka K et al (2013) Wharton's Jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications. Int J Mol Sci 14:11692-11712
18. Marcus AJ, Woodbury D (2008) Fetal stem cells from extra-embryonic tissues: do not discard. J Cell Mol Med 12(3):730-742
19. Pappa KI, Anagnou NP (2009) Novel sources of fetal stem cells: where do they fit on the developmental continuum? Regen Med 4:423-433
20. Badraiq H, Devito L, Ilic D (2014) Isolation and expansion of mesenchymal stromal/stem cells from umbilical cord under chemically defined conditions. Methods Mol Biol [Epub ahead of print]
21. Devito L, Badraiq H, Galleu A et al (2014) Wharton's Jelly MSC derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1+ subpopulation. Regen Med (in press)
22. Reubinoff BE, Pera MF, Vajta G et al (2001) Effective cryopreservation of human embryonic stem cells by the open pulled straw vitrification method. Hum Reprod 16:2187-2194
23. Ilic D, Stephenson E, Wood V et al (2012) Derivation and feeder-free propagation of human embryonic stem cells under xeno-free conditions. Cytotherapy 14:122-128
24. Stephenson E, Jacquet L, Miere C et al (2012) Derivation and propagation of human embryonic stem cell lines from frozen embryos in an animal product-free environment. Nat Protoc 7:1366-1381